Multicenter US study of hospital resource utilization associated with cytomegalovirus-related readmission of renal and heart transplant patients

Transplant Infectious Disease

Volumn 3, Issue , 2001, Pages 57-59

  Henderson, R ^a   Carlin, D ^a   Kohlhase, K ^a   Leader, S ^a  

^a MEDIMMUNE   (United States)

Author keywords

Costs; Heart transplant; Hospital utilization; Renal transplant

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS INFECTION; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL CARE; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

ADULT; CYTOMEGALOVIRUS INFECTIONS; HEALTH RESOURCES; HEART TRANSPLANTATION; HOSPITAL COSTS; HUMANS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; PATIENT READMISSION; UNITED STATES;

EID: 0035690831     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2001.00011.x     Document Type: Article

References (9)

1. Infection in the organ transplant recipient
2. Economic impact of cytomegalovirus in solid organ transplantation
3. A model for analyzing the cost of main clinical events after cardiac transplantation
4. Cytomegalovirus infections in heart transplant recipients
5. Risk factors for early, cumulative, and fatal infections after heart transplantation
6. Which renal transplant patients should receive cytomegalovirus immune globulin?
7. The cost of CMV disease in renal transplantation